Video Shorts
0:53
Transitioning from COO to CEO
a year ago
by
Mike Hollan(+1 more)
0:59
Obesity Medication's Unique Marketing Environment
a year ago
by
Mike Hollan
1:06
AI at FDA
a year ago
by
Mike Hollan
0:59
Preparing for Tariffs
a year ago
by
Mike Hollan
0:34
Federated Data Networks
a year ago
by
Mike Hollan
0:47
The Breakthrough of Multiomics
a year ago
by
Mike Hollan
1:01
Regulatory Uncertainty
a year ago
by
Mike Hollan
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
3
FDA Approves Daraxonrasib as First-in-Class Targeted Therapy for Metastatic Pancreatic Cancer
4
Pharmaceutical Executive Daily: Haisco Licenses Preclinical Immunology Asset to Sentivera
5